The deal intelligence
your committee expects.
14 engines. 12 therapeutic areas. 2,500+ transactions. Run rNPV, Monte Carlo, scenario modeling, and buyer-specific valuation — in under 30 seconds.
or $199/month billed annually
Total rNPV
$312M
+$87M option value
Cumulative PoS
24.3%
Ann. Return
18.4%
Payback
10.7y
rNPV
$312M
Implied Deal
$245M
Expected Value
$287M
Monte Carlo P50
$298M
Bear Floor
$85M
See What Pro Unlocks
Every feature designed for deal committees, not dashboards.
Bear, Base, and Bull — side by side
Model three scenarios simultaneously with different PoS, peak sales, and discount rate assumptions. See the probability-weighted expected value across all outcomes.
- Scenario-specific rNPV with custom assumptions
- Probability-weighted expected value
- Implied deal ranges for each case
- One-click PDF export for deal committee
Scenario Comparison
Bear
$85M
Deal: $28M
Base
$312M
Deal: $95M
Bull
$890M
Deal: $310M
Probability-Weighted Expected Value
$287M
Buyer-Specific Valuation
Generic Buyer
$245M
Upfront: $65M
AstraZeneca
$340M
+39% premium
Novartis
$295M
+20% premium
Negotiation Leverage
STRONGUpfront Premium
+$28MKnow what each buyer will pay — before the meeting
Compare Generic vs. up to 3 specific buyers side-by-side. The 5-factor strategic premium model accounts for portfolio fit, deal urgency, patent cliff pressure, pipeline gaps, and competitive pressure.
- 10-factor Pharma Intent Score per buyer
- Strategic premium capped at +75% (calibrated from 2,500+ deals)
- Negotiation leverage assessment
- Timing advantage analysis
850+ companies ranked by fit and acquisition intent
Our partner matching engine scores companies across modality alignment, pipeline gaps, patent cliff pressure, and deal velocity. The 10-factor Pharma Intent Score predicts who is most likely to transact in the next 12-18 months.
- Patent cliff revenue-at-risk analysis
- Pipeline gap detection from ClinicalTrials.gov
- Deal velocity and serial acquirer tracking
- Timing probability windows (6mo / 12mo / 18mo)
Top Partner Matches
14 Engines. One Platform.
Every engine runs in under 400ms. Results populate instantly.
Free vs Pro
See exactly what you unlock.
Built for the People Making the Decisions
BD Teams
Active out-licensing
Model every scenario before you walk into the room. Compare partner offers side-by-side with buyer-specific assumptions.
Deal Committees
Evaluating inbound offers
Generate board-ready reports in minutes. rNPV, Monte Carlo, and sensitivity analysis give your committee quantitative rigor.
Investors & Advisors
Portfolio valuations
Stress-test deal economics across bear/base/bull. Real options valuation captures the optionality your DCF models miss.
Questions
Can I cancel anytime?
What's included in the annual plan?
Do I get access to all therapeutic areas?
Can I export reports for my deal committee?
Stop guessing. Start benchmarking.
2,500+ transactions. 14 engines. Under 30 seconds.
or $199/month annually
Cancel anytime. No contracts.